|
|
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. |
First Approval Date26 Aug 2021 |
|
|
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.United States |
First Approval Date24 May 2018 |
100 Clinical Results associated with BioMarin Pharmaceutical Japan K.K.
0 Patents (Medical) associated with BioMarin Pharmaceutical Japan K.K.
100 Deals associated with BioMarin Pharmaceutical Japan K.K.
100 Translational Medicine associated with BioMarin Pharmaceutical Japan K.K.